In 1957 the FDA approved a medicine referred to as Enovid for treating menstrual issues and infertility. Three years later, this mix of the artificial hormones norethynodrel and mestranol, was authorised by doctors as a contraceptive.
The distinguished Canadian scientist, Dr Tak Mak, Director of the Advanced Medical Discovery Institute and the Campbell Family Institute for Breast Cancer Research, visited CRH on Monday 3 July to give a fascinating seminar on future anti-cancer targets.
The COST Action Mye-EUNITER is a network of scientists who are undertaking exploratory research into myeloid regulatory cells. The main objective is to establish technical standards for the characterisation and analysis of these cells.
The award winning research studied the role of macrophages in endometriosis associated pain and the presentation was entitled Macrophage-derived insulin-like growth factor-1 (IGF-1): a key player in endometriosis?
Specialist antenatal clinics for severely obese mums-to-be can help cut rates of pregnancy complications, research has found. Women who received the specialist care were eight times less likely to have a stillbirth.
Research being carried out at the MRC Centre for Reproductive Health into endometriosis could lead to new drug treatments that will block the development and progression of the often debilitating condition.
The MRC CRH welcomed Gordon and Sarah Brown and around 80 guests of the charity Theirworld to a gala event to celebrate the work of the Jennifer Brown Research Laboratory (JRBL), established in memory of Jennifer Brown in 2004.